Blog Posts by Tag: Laboratory
The 5 Keys to Minimizing the Impact of PAMA
At this year's Executive War College Conference, XIFIN CEO and Executive Chairman, Lâle White presented on PAMA’s effects on laboratories and gave some thought-provoking ideas on how labs can respond. This blog post will cover many of the topics that Lâle discussed, starting with this timeline of industry events which provides background on the laboratory reimbursement environment...
Accurate Patient Responsibility Estimates Dramatically Improve the Patient Experience
Customer experience is one of the most significant long-term differentiators in healthcare and diagnostics, as it is in virtually all other sectors. There is a direct correlation between customer experience and engagement, and consumers have been trained to expect more when it comes to service and experience by companies such as Amazon, Apple, and Southwest Airlines. A survey of 1,000 patients...
U.S. HealthTek: Considering a New LIS? What You Need to Know
Enjoy the following content from our strategic partner, U.S. Healthtek. Here at U.S. HealthTek, we’re seeing a greater interest in new and upgraded laboratory information systems (LIS). This is a little something I know about. When I started my career in the healthcare industry in the mid-1980s, one of my initial projects was to build a lab system for National...
Laboratory Economics' Anatomic Pathology & Clinical Lab Survey
Attention pathology groups! Laboratory Economics, an independent market research firm focused on the business of pathology and laboratory medicine, is conducting a survey to gain insight on current business trends among anatomic pathology groups and clinical labs. Please take a few moments to fill out this survey and in return for your participation, you will receive a full summary of the survey...
Digital Pathology Primary Diagnosis is Approved – Is Your Lab Ready for the Future?
Earlier this month, there was an exciting announcement that Leica received their FDA 510(k) clearance to market a digital pathology whole slide imaging system for primary diagnosis. This comes on the heels of Philips’ groundbreaking announcement of FDA clearance in late 2017, which was the first device ever cleared for primary diagnosis. These advancements are initiating significant momentum in...
How the Most Successful Laboratories in the Country Continue to Thrive in the Midst of an Increasingly Complex Reimbursement Environment
The business of laboratory revenue cycle management (RCM) becomes more complex every day; with reductions in reimbursement, increasing rejections and denials, payor specific billing rules, shifting financial reporting and accounting requirements (PAMA, FASB ASC 606, medical economics reporting), OIG and EKRA (false claims) compliance standards, malware and ransomware attacks, etc. Once there was...
Hidden Landmines in Revenue Cycle Management: 4 Rules of Report Analysis to Follow (Part 3)
This is the third post of a three-part blog series focused on key areas of business performance management for pathology practices, diagnostic laboratories, and molecular diagnostic providers. The other blog posts in this series can be found here: Part 1 and Part 2 At the recent Executive War College, I had the honor of presenting with Diana Richard and...
Hidden Landmines in Revenue Cycle Management: Misleading Metrics (Part 2)
This is the second post of a three-part blog series focused on key areas of business performance management for pathology practices, diagnostic laboratories, and molecular diagnostic providers. The other blog posts in this series can be found here: Part 1 and Part 3 Below, we have detailed the need for a complete understanding of the drivers behind the metrics...
- 1 of 3
- next ›